EXTH-76. PRMT5 INHIBITION SENSITIZES GLIOBLASTOMA NEUROSPHERES TO TEMOZOLOMIDE
Sarah Rivas(National Institutes of Health), Yeshavanath Banasavadi-Siddegowda(National Institutes of Health), Kimberly Rivera-Caraballo(The University of Texas Health Science Center), Sara A. Murphy(The University of Texas Health Science Center), Yuanqing Yan(Northwestern University), Stuart Walbridge(National Institutes of Health), Balveen Kaur(Augusta University), Yoshihiro Otani(Okayama University), Ashish H. Shah(University of Miami), John D. Heiss(National Institutes of Health), Dragan Maric(National Institute of Neurological Disorders and Stroke), Allison Shelbourn(National Institutes of Health), Leo Ampie(National Institutes of Health), Ji Young Yoo(The University of Texas MD Anderson Cancer Center)
Cited by 1
Related Papers
Near real-time intraoperative brain tumor diagnosis using stimulated Raman histology and deep neural networks
|Nature Medicine|2020|768
Microvascular Injury in the Brains of Patients with Covid-19
|New England Journal of Medicine|2020|603
Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast
|Proceedings of the National Academy of Sciences|2010|433
PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy
|Cell stem cell|2018|423